Skip to main content
Original Research, Venetoclax, Chemotherapy, Leukemia
Evaluation of Outcomes and Adverse Events of a Hypomethylating Agent Plus Venetoclax Versus 7+3 Induction Chemotherapy in Patients Aged 50 to 70 Years
Robin Tumlinson, PharmD; Erin Kennedy, PharmD, BCOP; Alice Parish, MSPH; Alaattin Erkanli, PhD
Read More
Practical Issues in Pharmacy Management, Leukemia
Financial Impact and Utilization of a Pharmacist-Driven Home Infusion Pathway for Blinatumomab in Patients Requiring Short-Term Inpatient Monitoring After Outpatient Initiation of Blinatumomab
Kelsea Seago, PharmD, BCOP, Charles M. Gallagher, PharmD; Spencer K. Yingling, PharmD, BCOP; Aaron Cumpston, PharmD, BCOP
Read More
Symptom Management Overview
Identification, Significance, and Management of Complement Inhibitor–Induced Headaches in Patients With Paroxysmal Nocturnal Hemoglobinuria
Lindsey Fold, PharmD; Nina Inayan, PharmD; Justin Arnall, PharmD, BCOP, FCCP
Read More
Online First
Case Reports, Adverse Events, Chemotherapy
Irinotecan-Induced Hypertonia: A Case Report
Vallabhi Mishra, PharmD; Krutika Gohil, MBBS; Alyssa Tian Gu, BS Candidate; Alexandra Zhikharev, BS Candidate; Minaxi Jhawer, MD
Read More
Clinical Trials
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
Read More
Online First
Original Research, Chemotherapy
Financial Effect of Automated Chemotherapy Dose Rounding at an Academic Medical Center
Keeyan Davis, PharmD; Junyu Matt Zhang, PharmD, BCOP, BCPS; Katherine Moser, PharmD, BCPS
Read More
HOPA Corner
DLL3-Targeting BiTE Therapy in SCLC: A Pharmacist’s Guide to Evidence and Integration
Read More
HOPA Corner
Checkpoint Inhibitors: Changing Colorectal Cancer Treatment
Read More
Clinical Trials
The Evolution of Abemaciclib Clinical Trial Data for the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer
Read More
HOPA Corner
505(b)(2) Drugs: New Chaos for Infusion Centers
Read More
Page 7 of 193
Results 61 - 70 of 1925